Health actions after direct-to-consumer genetic testing for medically actionable conditions.
Saved in:
| Title: | Health actions after direct-to-consumer genetic testing for medically actionable conditions. |
|---|---|
| Authors: | Sturm AC; 23andMe Research Institute, Palo Alto, CA.; Ohio State University Wexner Medical Center, Columbus, OH., Detweiler S; 23andMe Research Institute, Palo Alto, CA., Bielenberg J; 23andMe Research Institute, Palo Alto, CA., Park S; 23andMe Research Institute, Palo Alto, CA., Ukandu E; 23andMe Research Institute, Palo Alto, CA., Llorin H; 23andMe Research Institute, Palo Alto, CA., Elson SL; 23andMe Research Institute, Palo Alto, CA., McIntyre MH; 23andMe Research Institute, Palo Alto, CA., Abul-Husn NS; 23andMe Research Institute, Palo Alto, CA.; Icahn School of Medicine at Mount Sinai, New York, NY. |
| Corporate Authors: | 23andMe Research Team |
| Source: | Genetics in medicine open [Genet Med Open] 2026 Feb 16; Vol. 4, pp. 104390. Date of Electronic Publication: 2026 Feb 16 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918734281906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2949-7744 (Electronic) Linking ISSN: 29497744 NLM ISO Abbreviation: Genet Med Open Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2949-7744 |
|---|---|
| DOI: | 10.1016/j.gimo.2026.104390 |
